[Can diabetic polyneuropathy be successfully treated?].
Ziegler
Dan
D
Institut für Klinische Diabetologie, Deutsches Diabetes-Zentrum an der Heinrich-Heine-Universität, Leibniz-Zentrum für Diabetesforschung, Universitätsklinikum Düsseldorf. dan.ziegler@ddz.uni-duesseldorf.de
D000700:Analgesics / Q000009:adverse effects / Q000627:therapeutic use; D000701:Analgesics, Opioid / Q000009:adverse effects / Q000627:therapeutic use; D000927:Anticonvulsants / Q000009:adverse effects / Q000627:therapeutic use; D000928:Antidepressive Agents / Q000009:adverse effects / Q000627:therapeutic use; D003131:Combined Modality Therapy; D003929:Diabetic Neuropathies / Q000175:diagnosis / Q000628:therapy*; D004359:Drug Therapy, Combination; D006801:Humans; D009460:Neurologic Examination
D000700:Analgesics; D000701:Analgesics, Opioid; D000927:Anticonvulsants; D000928:Antidepressive Agents